Terms ending in 2037
Every in-force patent on Sanbio, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,553,033 | Medium, Methods, Cells and Secreted Factors for Stem Cell Culture and Therapy In force · Medium confidence | Sanbio, Inc. | In force | Medium confidence | |
| US 11,406,685 | Methods and Compositions for Stimulation of Cell Proliferation and Provision of Biologically Active Mixtures of FGF2 Isoforms In force · Medium confidence | Sanbio, Inc. | In force | Medium confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.